Antiangiogenic therapy using bevacizumab in recurrent high-grade glioma: impact on local control and patient survival

OBJECT: Antiangiogenic agents have recently shown impressive radiological responses in high-grade glioma. However, it is not clear if the responses are related to vascular changes or due to antitumoral effects. The authors report the mature results of a clinical study of bevacizumab-based treatment ... View More